647863-01-2 Usage
Uses
Used in Pharmaceutical Industry:
7-Benzyl-4-chloro-2-(trifluoromethyl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine is used as a pharmaceutical compound for its potential antiviral and anticancer properties. Its unique structure allows it to target specific biological pathways, making it a promising candidate for the development of new drugs to treat viral infections and cancer.
Used in Antiviral Applications:
7-Benzyl-4-chloro-2-(trifluoromethyl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine is used as an antiviral agent, targeting specific viral proteins or enzymes to inhibit viral replication and reduce the severity of infections. Its unique chemical properties enable it to interact with viral components, making it a potential candidate for the development of new antiviral drugs.
Used in Anticancer Applications:
7-Benzyl-4-chloro-2-(trifluoromethyl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine is used as an anticancer agent, exhibiting potential to inhibit the growth and proliferation of cancer cells. Its unique structure allows it to target specific cellular pathways involved in cancer development and progression, making it a promising candidate for the development of new cancer therapies.
Used in Drug Development Research:
7-Benzyl-4-chloro-2-(trifluoromethyl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine is used as a research compound in drug development, providing insights into its biological activities and potential applications. Its unique structure and chemical properties make it an interesting candidate for further investigation, with the aim of discovering new drugs to treat various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 647863-01-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,4,7,8,6 and 3 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 647863-01:
(8*6)+(7*4)+(6*7)+(5*8)+(4*6)+(3*3)+(2*0)+(1*1)=192
192 % 10 = 2
So 647863-01-2 is a valid CAS Registry Number.
InChI:InChI=1/C15H13ClF3N3/c16-13-11-6-7-22(8-10-4-2-1-3-5-10)9-12(11)20-14(21-13)15(17,18)19/h1-5H,6-9H2
647863-01-2Relevant academic research and scientific papers
AMINOCYCLOHEXANES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
-
Page/Page column 47, (2008/06/13)
The present invention is directed to novel substituted aminocyclohexanes which are inhibitors of the dipeptidyl peptidase-IV enzyme ("DPP-IV inhibitors") and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
FUSED TRIAZOLE DERIVATIVES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
-
Page/Page column 45, (2008/06/13)
The present invention is directed to novel fused triazole derivatives which are inhibitors of the dipeptidyl peptidase-IV enzyme ("DPP-IV inhibitors") and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
PIPERIDINO PYRIMIDINE DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OF DIABETES
-
Page 49, (2008/06/13)
The present invention is directed to compounds which are inhibitors of the dipeptidyl peptidase-IV enzyme ("DP-IV inhibitors") and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
